Correlation Between Knight Therapeutics and CTT Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Knight Therapeutics and CTT Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Knight Therapeutics and CTT Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Knight Therapeutics and CTT Pharmaceutical Holdings, you can compare the effects of market volatilities on Knight Therapeutics and CTT Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Knight Therapeutics with a short position of CTT Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Knight Therapeutics and CTT Pharmaceutical.

Diversification Opportunities for Knight Therapeutics and CTT Pharmaceutical

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between Knight and CTT is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Knight Therapeutics and CTT Pharmaceutical Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CTT Pharmaceutical and Knight Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Knight Therapeutics are associated (or correlated) with CTT Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CTT Pharmaceutical has no effect on the direction of Knight Therapeutics i.e., Knight Therapeutics and CTT Pharmaceutical go up and down completely randomly.

Pair Corralation between Knight Therapeutics and CTT Pharmaceutical

Assuming the 90 days horizon Knight Therapeutics is expected to under-perform the CTT Pharmaceutical. But the pink sheet apears to be less risky and, when comparing its historical volatility, Knight Therapeutics is 2.9 times less risky than CTT Pharmaceutical. The pink sheet trades about -0.18 of its potential returns per unit of risk. The CTT Pharmaceutical Holdings is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  6.07  in CTT Pharmaceutical Holdings on August 29, 2024 and sell it today you would lose (0.27) from holding CTT Pharmaceutical Holdings or give up 4.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Knight Therapeutics  vs.  CTT Pharmaceutical Holdings

 Performance 
       Timeline  
Knight Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Knight Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
CTT Pharmaceutical 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in CTT Pharmaceutical Holdings are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, CTT Pharmaceutical demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Knight Therapeutics and CTT Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Knight Therapeutics and CTT Pharmaceutical

The main advantage of trading using opposite Knight Therapeutics and CTT Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Knight Therapeutics position performs unexpectedly, CTT Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CTT Pharmaceutical will offset losses from the drop in CTT Pharmaceutical's long position.
The idea behind Knight Therapeutics and CTT Pharmaceutical Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Money Managers
Screen money managers from public funds and ETFs managed around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets